Transferrin Receptor-Targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy
International Journal of Nanomedicine - New Zealand
doi 10.2147/ijn.s187240
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2018
Authors
Publisher
Informa UK Limited